Moderna

MRNA

Moderna is an American biotechnology company based in Cambridge, Massachusetts that focus on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA).

Moderna has been a target of short sellers for a while. The current short interest of 9.81% is significantly below the average of the last 12 months (15.39%).